Evidence map›Paper›PMID 33447542›Full record

ArticleGland surgery2020

Expressions of microRNA-29a and microRNA-34a in pleomorphic adenomas of salivary glands.

Igor Sergeevich Brodetskyi, Vladislav O Malanchuk, Victor E Dosenko

Open access · diamondAbstract read
In one paragraph

Article in Gland surgery, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
1.2field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 12 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Igor Sergeevich BrodetskyiDepartment of Oral and Maxillofacial Surgery, Bogomolets National Medical University, Kyiv, Ukraine.
Vladislav O MalanchukDepartment of Oral and Maxillofacial Surgery, Bogomolets National Medical University, Kyiv, Ukraine.
Victor E DosenkoDepartment of General and Molecular Pathophysiology, Bogomoletz Institute of Physiology, NAS of Ukraine, Kyiv, Ukraine.
Bogomolets National Medical University · UABogomoletz Institute of Physiology · UA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe most common type of salivary gland tumor is pleomorphic adenoma. The genetic area of focus in the diagnosis of salivary gland tumors is a study of the role of miRNA.

methodsTwenty-two patients with pleomorphic adenomas of the salivary glands were used for the examinations. The histological typing of the salivary gland tumors was performed when using routine staining with hematoxylin and eosin, as well as with immunohistochemistry. The expressions of miR-34a and miR-29a were evaluated by using reverse transcription and the quantitative polymerase chain reaction in a real-time setting. In addition, the study also calculated the levels of expression of miR-29a and miR-34a in the venous blood.

resultsThe majority of patients-15 (68.18%) and 22 (100.00%) had a positive response to human papillomavirus (HPV) and pleomorphic adenoma gene 1 (PLAG1), respectively. The conducted analyses of the expressions of miR-34a and miR-29a showed that the highest expression was observed in the salivary gland tissue adjacent to the tumor (1,052.02±367.20 and 111.93±56.97, versus 47.72±28.93 and 8.12±4.40 in the intact salivary gland tissue, respectively).

conclusionsThere was a sufficiently high level of miR-34a and miR-29a expressions in the tissues of the tumor of pleomorphic adenomas of the salivary glands when compared with the intact salivary gland tissue.

Indexed as

apoptosiscorrelation analysisMiR-29a expressionmiR-34a expressionpleomorphic adenomassalivary glands

Identifiers

PMID33447542
PMCPMC7804538
OpenAlexW3108761813

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.